The global joint reconstruction market is projected to grow at a CAGR of 5.0% from 2014 to 2019. Growing demand of minimally invasive techniques in joint reconstruction, and awareness about the benefits associated with joint reconstruction surgeries are significant factors driving its market growth. The knee replacement segment of the global joint replacement market was valued at $7,721.0 million in 2014, and is projected to reach $9,826.8 million by 2019, at a CAGR of 4.9% during the forecast period.
In this report, the global joint reconstruction market is broadly classified on the basis of type and geography. According to type, the market is segmented into ankle replacement, digit replacement, elbow replacement, hip replacement, knee replacement, shoulder replacement, and elbow replacement. Similarly, on the basis of geography, the market is classified into North America, Europe, Asia-Pacific, and rest of the world. Among all regions, the joint reconstruction market in North America accounted for the largest market share of 57.8% in 2014.
Globally, there is a huge population of patients suffering from rheumatoid arthritis and osteoarthritis, which in turn, is fostering the advancement of new technologies and product launch made by key players in the joint reconstruction market.
The report has profiled the leading players of this market, along with recent developments (new product launches and partnerships, agreements, collaborations, and joint ventures) undertaken by the companies over the past few years, and key growth strategies adopted by them to sustain and strengthen their position in the global joint reconstruction market. Zimmer Holding Inc. (U.S.), Depuy Synthes Companies (Germany), Stryker Corporation (U.S.), Biomet Inc. (U.S.), and Smith & Nephew Plc. (U.K.), are some of the key players thriving in this market.
